Clinical trial of 2-Br- -ergocryptine (CB154) in advanced breast cancer.
D000284:Administration, Oral; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D001966:Bromine / Q000008:administration & dosage / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004876:Ergot Alkaloids / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008593:Menopause
D000970:Antineoplastic Agents; D004876:Ergot Alkaloids; D001966:Bromine